除細動器市場：タイプ別、エンドユーザー別、患者タイプ別-2025-2030年の世界予測

除細動器市場の2023年の市場規模は140億7,000万米ドルで、2024年には149億6,000万米ドルに達すると予測され、CAGR 6.77％で成長し、2030年には222億7,000万米ドルに達すると予測されています。

除細動器市場には、心臓に電気パルスまたは電気ショックを送ることによって正常な心拍を回復させるために使用されるさまざまな医療機器が含まれます。これらの機器は、生命を脅かす心臓不整脈、心室細動、無脈性心室頻拍の治療に極めて重要です。その必要性は、主に心血管系疾患の世界の増加と突然の心停止の有病率の増加から生じており、緊急対応や公共スペース、病院、家庭で不可欠なものとなっています。自動体外式除細動器（AED）、埋め込み型除細動器、ウェアラブル除細動器など、さまざまな形態の除細動器があり、病院、病院前、救急車、家庭など、さまざまなエンドユーザーに対応しています。

市場成長は、技術の進歩、高齢化、社会意識の向上、AED配備を促進する政府の有利な政策などの要因に影響されます。除細動器の普及率が低い新興市場、より優れた予測分析のためのAIと機械学習の進歩、ポータブル除細動器とウェアラブル除細動器技術の新たな動向などには機会が豊富です。こうした機会を捉えるための推奨事項としては、特にウェアラブル技術における研究開発による製品提供の拡大、未開拓地域における流通のための戦略的パートナーシップなどが挙げられます。

しかし、高い機器コスト、厳しい規制承認プロセス、未開発地域における認識不足が成長の課題となっています。革新的な機会は、費用対効果の高いモデルの開発、リアルタイムのモニタリングのための接続性の強化、アクセス性と応答時間を改善するための遠隔医療プラットフォームとの除細動器の統合にあります。市場の性質は、医療専門家と一般人の双方に力を与えるユーザーフレンドリーでスマートな機器へのシフトとともに進化し続けています。要するに、除細動器市場は医療機器産業のダイナミックで不可欠な構成要素であり、世界的に拡大する医療ニーズに対応するために絶えず革新を続け、コスト削減と技術統合の改善に重点を置いて、患者の転帰全体を向上させています。

市場力学：急速に進化する除細動器市場の主要市場インサイトを公開

除細動器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心臓疾患の急増
  • 公共の場における除細動器の利用可能性の高まりと、それに伴うトレーニングや意識向上プログラム
  • 除細動器の採用増加に対する有利な支援規制
• 市場抑制要因
  • 植込み型および自動体外式除細動器の適用に関する懸念
• 市場機会
  • S-ICD、MRI対応およびCRT-Dsの開発が進行中
  • プレホスピタル環境における自動体外式除細動器の需要の高まり
• 市場の課題
  • 故障や頻繁な製品リコール

ポーターの5つの力：除細動器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、除細動器市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：除細動器市場における外部からの影響の把握

外部マクロ環境要因は、除細動器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析除細動器市場における競合情勢の把握

除細動器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス除細動器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、除細動器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨除細動器市場における成功への道筋を描く

除細動器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心臓疾患の発生率の急増
    • 公共の場での除細動器の利用可能性の向上と、トレーニングおよび意識向上プログラム
    • 除細動器の採用拡大に向けた有利な支援規制
  • 抑制要因
    • 埋め込み型および自動外部システムの適用に関する懸念除細動器
  • 機会
    • S-ICD、MRI対応、CRT-Dの開発が進行中
    • 病院前環境における自動化された外部除細動器の需要の高まり
  • 課題
    • 故障や頻繁な製品リコール
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 除細動器市場：タイプ別

• 外部除細動器
• 植込み型除細動器除細動器
  • 皮下植込み型除細動器除細動器
  • 経静脈皮下植込み型除細動器除細動器
    • 両室ICD/心臓再同期療法除細動器
    • デュアルチャンバーICD
    • 単腔型ICD

第7章 除細動器市場：エンドユーザー別

• 代替ケア施設
• ホームケア設定
• 病院、診療所、心臓センター
• 病院前ケアの現場

第8章 除細動器市場患者タイプ別

• 成人用
• 小児科

第9章 南北アメリカの除細動器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の除細動器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの除細動器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AMI Italia S.r.l.
• Axion Ltd.
• Baxter International Inc.
• Bexen Cardio By Osatu S Coop
• Biotronik SE & CoKG
• Boston Scientific Corporation
• CU Medical Systems, Inc.
• GE Healthcare
• Koninklijke Philips N.V.
• LivaNova PLC
• Mediana Co., Ltd.
• Medtonic PLC
• Metsis Medikal
• MicroPort Scientific Corporation
• Narang Medical Limited
• Nihon Kohden Corporation
• Olympus Corporation
• Progetti Srl
• Schiller AG
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Stryker Corporation
• Thermo Fisher Scientific Inc.
• ZOLL Medical Corporation

LIST OF FIGURES

• FIGURE 1. DEFIBRILLATORS MARKET RESEARCH PROCESS
• FIGURE 2. DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DEFIBRILLATORS MARKET DYNAMICS
• TABLE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ALTERNATE CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PREHOSPITAL CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ITALY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. POLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. QATAR DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

The Defibrillators Market was valued at USD 14.07 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 6.77%, to USD 22.27 billion by 2030.

The defibrillator market encompasses a range of medical devices used to restore a normal heartbeat by sending an electric pulse or shock to the heart. These devices are crucial in treating life-threatening cardiac dysrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia. Necessity arises primarily from the global rise in cardiovascular diseases and the increasing prevalence of sudden cardiac arrests, making them vital in emergency responses and public spaces, hospitals, and homes. The application scope extends across various forms of defibrillators, including Automated External Defibrillators (AEDs), implanted defibrillators, and wearable defibrillators, catering to different end users such as hospitals, pre-hospital settings, ambulances, and households.

Market growth is influenced by factors like technological advancements, the aging population, increased public awareness, and favorable governmental policies promoting AED deployment. Opportunities abound in emerging markets with low defibrillator penetration, advancements in AI and machine learning for better predictive analytics, and emerging trends in portable and wearable defibrillator technologies. Recommendations to capture these opportunities include expanding product offerings through R&D, especially in wearable technologies, and strategic partnerships for distribution in untapped regions.

However, growth is challenged by high device costs, stringent regulatory approval processes, and lack of awareness in underdeveloped regions. Innovative opportunities lie in developing cost-effective models, enhancing connectivity for real-time monitoring, and integrating defibrillators with telehealth platforms to improve accessibility and response times. The market's nature continues to evolve with a shift towards user-friendly, smart devices that empower both medical professionals and laypersons. In essence, the defibrillator market is a dynamic and essential component of the medical devices industry, constantly innovating to meet the growing health needs globally, with a focus on reducing costs and improving technological integration to enhance overall patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Defibrillators Market

The Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surging incidences of cardiac disorders
  • Rising availability of defibrillators in public places coupled with training and awareness programs
  • Favorable supportive regulations for increased adoption of defibrillators
• Market Restraints
  • Concerns pertinent to application of implantable and automated external defibrillators
• Market Opportunities
  • Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
  • Emerging demand for automated external defibrillators in prehospital environment
• Market Challenges
  • Failure or frequent product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Defibrillators Market

A detailed market share analysis in the Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Defibrillators Market

A strategic analysis of the Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI Italia S.r.l., Axion Ltd., Baxter International Inc., Bexen Cardio By Osatu S Coop, Biotronik SE & CoKG, Boston Scientific Corporation, CU Medical Systems, Inc., GE Healthcare, Koninklijke Philips N.V., LivaNova PLC, Mediana Co., Ltd., Medtonic PLC, Metsis Medikal, MicroPort Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Olympus Corporation, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across External Defibrillators and Implantable Cardioverter Defibrillators. The Implantable Cardioverter Defibrillators is further studied across Subcutaneous Implantable Cardioverter Defibrillators and TransvenoSubcutaneous Implantable Cardioverter Defibrillators. The TransvenoSubcutaneous Implantable Cardioverter Defibrillators is further studied across Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICDs, and Single-Chamber ICDs.
• Based on End-User, market is studied across Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers, and Prehospital Care Settings.
• Based on Patient Type, market is studied across Adult and Pediatric.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surging incidences of cardiac disorders
    • 5.1.1.2. Rising availability of defibrillators in public places coupled with training and awareness programs
    • 5.1.1.3. Favorable supportive regulations for increased adoption of defibrillators
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns pertinent to application of implantable and automated external defibrillators
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
    • 5.1.3.2. Emerging demand for automated external defibrillators in prehospital environment
  • 5.1.4. Challenges
    • 5.1.4.1. Failure or frequent product recalls
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Defibrillators Market, by Type

• 6.1. Introduction
• 6.2. External Defibrillators
• 6.3. Implantable Cardioverter Defibrillators
  • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillators
  • 6.3.2. TransvenoSubcutaneous Implantable Cardioverter Defibrillators
    • 6.3.2.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators
    • 6.3.2.2. Dual-Chamber ICDs
    • 6.3.2.3. Single-Chamber ICDs

7. Defibrillators Market, by End-User

• 7.1. Introduction
• 7.2. Alternate Care Facilities
• 7.3. Home Care Settings
• 7.4. Hospitals, Clinics, & Cardiac Centers
• 7.5. Prehospital Care Settings

8. Defibrillators Market, by Patient Type

• 8.1. Introduction
• 8.2. Adult
• 8.3. Pediatric

9. Americas Defibrillators Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Defibrillators Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Defibrillators Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMI Italia S.r.l.
• 3. Axion Ltd.
• 4. Baxter International Inc.
• 5. Bexen Cardio By Osatu S Coop
• 6. Biotronik SE & CoKG
• 7. Boston Scientific Corporation
• 8. CU Medical Systems, Inc.
• 9. GE Healthcare
• 10. Koninklijke Philips N.V.
• 11. LivaNova PLC
• 12. Mediana Co., Ltd.
• 13. Medtonic PLC
• 14. Metsis Medikal
• 15. MicroPort Scientific Corporation
• 16. Narang Medical Limited
• 17. Nihon Kohden Corporation
• 18. Olympus Corporation
• 19. Progetti Srl
• 20. Schiller AG
• 21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 22. Stryker Corporation
• 23. Thermo Fisher Scientific Inc.
• 24. ZOLL Medical Corporation